FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Erythromycin Lactobionate for Injection, USP
Status: Currently in Shortage
»Date first posted: 05/21/2018
»Therapeutic Categories: Anti-Infective

Expand all

Hospira, Inc. (Reverified 08/08/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg Single Dose Glass Fliptop Vial (NDC 00409-6482-01) Next Delivery and Estimated Recovery: 2019 Shortage per Manufacturer: Manufacturing Delay Other
500 mg Single-dose ADD-Vantage® Vial (NDC 00409-6476-44) Next Delivery and Estimated Recovery: 2019 Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English